[Suppurative surgical infection in newborn infants and the clinico-immunological effect of using dekaris].
D001424:Bacterial Infections / Q000188:drug therapy* / Q000276:immunology / Q000601:surgery; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D007231:Infant, Newborn; D007958:Leukocyte Count / Q000187:drug effects; D007978:Levamisole / Q000627:therapeutic use*; D010019:Osteomyelitis / Q000188:drug therapy / Q000276:immunology / Q000601:surgery; D010587:Phagocytosis / Q000187:drug effects; D018805:Sepsis / Q000188:drug therapy / Q000276:immunology / Q000601:surgery; D013530:Surgical Wound Infection / Q000188:drug therapy / Q000276:immunology / Q000601:surgery
D007978:Levamisole
Gnoĭnaia khirurgicheskaia infektsiia novorozhdennykh i kliniko-immunologicheskiĭ éffekt primeneniia dekarisa.